Proteomic analysis of colon cancer tissues using combination of Seldi-Tof mass Spectrometry and 2d gel electrophoresis

被引：0
|
作者：
Chen, AL
Soman, KV
Luxon, BA
Evers, BM
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A491 / A491
页数：1
相关论文
共 50 条
  • [41] SELDI-TOF mass spectrometry reveals distinctive protein expression profiles in the urine of bladder cancer patients
    Junker, K
    Mueller, J
    Driesch, D
    von Eggeling, F
    Schubert, J
    JOURNAL OF UROLOGY, 2005, 173 (04): : 165 - 165
  • [42] Identification of a novel protein profile of urothelial carcinoma (UCa) in urine using SELDI-TOF mass spectrometry
    Mendrinos, SE
    Angeletti, C
    Keane, T
    Petros, JA
    Amin, MB
    MODERN PATHOLOGY, 2002, 15 (01) : 174A - 174A
  • [43] Analysis and classification of proteomic profiles in breast cancer via a combined cytology/SELDI-TOF technique.
    Nolen, JL
    Mendrinos, S
    Skountzou, I
    Ritchie, JC
    Lewis, MM
    CLINICAL CHEMISTRY, 2003, 49 (06) : A14 - A14
  • [44] C-Terminal sequencing of peptide hormones using carboxypeptidase Y and SELDI-TOF mass spectrometry
    Cool, DR
    Hardiman, A
    BIOTECHNIQUES, 2004, 36 (01) : 32 - 34
  • [45] Identification of a novel protein profile of urothelial carcinoma (UCa) in urine using SELDI-TOF mass spectrometry
    Mendrinos, SE
    Angeletti, C
    Keane, T
    Petros, JA
    Amin, MB
    LABORATORY INVESTIGATION, 2002, 82 (01) : 174A - 174A
  • [46] Proteomic analysis of serum biomarkers in patients with nonalcoholic steatohepatitis using SELDI-TOF/MS or MALDI-TOF/MS
    Uto, Hirofumi
    Sato, Yuko
    Ishida, Yoichi
    Takami, Yoichiro
    Kanmura, Shuji
    Moriuchi, Akihiro
    Hasegawa, Susumu
    Oketani, Makoto
    Ido, Akio
    Nakajima, Tomoaki
    Okanoue, Takeshi
    Tsubouchi, Horohito
    HEPATOLOGY, 2007, 46 (04) : 735A - 736A
  • [47] The identification of proteins associated with cisplatin resistance in human breast cancer cells using 2D gel electrophoresis and MALDI-TOF mass spectrometry.
    Smith, L.
    Watson, M. B.
    Welham, K. J.
    Drew, P. J.
    Lind, M. J.
    Cawkwell, L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S247 - S248
  • [48] Differential proteomic analysis of the effects of immunosuppressant, Cyclosporine A and rapamycin, on squamous cell carcinoma by 2D difference gel electrophoresis and mass spectrometry
    Wang, C.
    Barnes, S.
    Beatrous, S.
    Herring, R.
    Wilson, L.
    Elmets, C.
    Athar, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S35 - S35
  • [49] Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry
    Wilson, LL
    Tran, L
    Morton, DL
    Hoon, DSB
    CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 : 317 - 322
  • [50] Cancer biomarker discovery;: a novel approach to obtain increased proteomic coverage in serum profiles using SELDI-TOF
    Pernemalm, M.
    Lehtio, J.
    Lewensohn, R.
    De Petris, L.
    Koy, H.
    Branden, E.
    Brattstrom, D.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S125 - S125
12345